Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid- Range Ejection Fraction | Zendy

Ewa A. Jankowska | Zendy; Andrew J.S. Coats | Zendy; Stefan D. Anker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid- Range Ejection Fraction

Author(s) -

Ewa A. Jankowska,

Andrew J.S. Coats,

Stefan D. Anker

Publication year - 2017

Publication title -

international cardiovascular forum journal

Language(s) - English

Resource type - Journals

eISSN - 2410-2636

pISSN - 2409-3424

DOI - 10.17987/icfj.v10i0.431

Subject(s) - ejection fraction , heart failure , medicine , cardiology , heart failure with preserved ejection fraction , fraction (chemistry) , intensive care medicine , chemistry , organic chemistry

In this article we discuss the treatment of heart failure (HF) with preserved ejection fraction (HFpEF) and of HF with mid-range ejection fraction (HFmrEF) as has received considerable interest since the publciation of the 2016 European Society of Cardiology (ESC) heart failure guidelines. Since clinical trials on HFpEF have included also patients with HFmrEF, due to the lack of an agreed definition, the ESC recommendations here described apply to both phenotypes. As a consequence of the recent characterisation of this HF syndrome, it is expected that upcoming research will provide data specifically regarding HFmrEF and tailored recommendations will be developed in the future.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research